India Administers Over 1 Crore HPV Vaccine Doses in Nine Months, Strengthening Cervical Cancer Prevention

National vaccination campaign achieves nearly 87 per cent coverage of its target population, with six states reporting complete coverage among identified eligible girls.

NEW DELHI, Nov 21: India has crossed a significant milestone in its fight against cervical cancer, with more than one crore doses of the Human Papillomavirus (HPV) vaccine administered under the National HPV Vaccination Campaign in less than nine months since its launch. The achievement highlights the country’s expanding focus on preventive healthcare and efforts to protect adolescent girls from infections that can lead to cervical cancer.

According to the Union Ministry of Health and Family Welfare, the nationwide programme has achieved nearly 87 per cent coverage of its identified annual target population of approximately 1.2 crore girls. The campaign, launched by Prime Minister Narendra Modi in February 2026, offers free and voluntary single-dose HPV vaccination to 14-year-old girls at designated government health facilities, subject to parental consent.

The milestone represents an important development in India’s public health strategy, particularly in addressing diseases that can be prevented through timely vaccination. Health authorities have been working with state governments, medical institutions, frontline workers, teachers and local communities to increase awareness and encourage families to participate in the programme.

Cervical cancer remains a major public health concern among women, with persistent infection from certain high-risk types of HPV responsible for the vast majority of cases. Medical experts have consistently emphasised the importance of vaccination before potential exposure to the virus, making adolescence an important period for preventive intervention.

Six States Achieve Complete Coverage

The vaccination campaign has recorded substantial progress across different regions, with six states achieving 100 per cent coverage of their identified target populations. These states are Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar.

Several other states have also reported strong performance. Assam recorded 95.63 per cent coverage, followed by Telangana at 95.28 per cent, Karnataka at 93.16 per cent and Uttarakhand at 90.17 per cent.

Chhattisgarh achieved 86.21 per cent coverage, while Rajasthan reported 85.23 per cent. Kerala recorded 77.02 per cent, Tamil Nadu 76.12 per cent and Odisha 74.90 per cent. The Union Territory of Dadra and Nagar Haveli and Daman and Diu registered 72.99 per cent coverage.

In terms of the total number of beneficiaries, Uttar Pradesh emerged as the leading state, with more than 29.33 lakh girls vaccinated. Bihar followed with over 13.70 lakh beneficiaries, while Gujarat reported more than 7.75 lakh vaccinations.

The figures indicate the extensive reach of the programme across states with different population sizes, geographical conditions and healthcare requirements. They also underline the importance of state-level planning in implementing a nationwide vaccination initiative.

The Health Ministry has attributed the progress to coordination between the Centre and state administrations, supported by district health officials, public hospitals and community-level workers.

HPV Vaccination and Its Importance

Human Papillomavirus is a common group of viruses, with certain high-risk strains associated with cervical cancer and other HPV-related diseases. While most HPV infections clear naturally, persistent infection with high-risk types can cause cellular changes that may eventually develop into cancer.

Cervical cancer affects the cervix, the lower part of the uterus connecting it to the vagina. The disease can develop over several years, often without noticeable symptoms during its early stages. This makes preventive measures, regular screening and timely medical attention particularly important.

HPV vaccination is considered one of the most effective ways to prevent infections caused by the virus types targeted by the vaccine. By providing vaccination to girls at the age of 14, the national programme aims to establish protection before possible exposure to HPV.

The Health Ministry has noted that more than 800 million HPV vaccine doses have been administered worldwide. Nearly two decades of scientific research and real world experience have demonstrated strong protection against vaccine-targeted HPV infections and associated precancerous conditions.

However, vaccination does not eliminate the need for cervical cancer screening later in life. Public health experts continue to emphasise that vaccination and screening are complementary approaches to reducing the disease burden.

Digital Platform Strengthens Monitoring

Digital infrastructure has emerged as an important component of the national vaccination drive. The government’s U-WIN platform is being used to monitor vaccination progress, maintain beneficiary records and improve access to vaccination services.

The platform enables health authorities to track beneficiaries in real time and identify areas where coverage remains low. District-level officials can use the information to identify eligible girls who have not yet received the vaccine and organise additional outreach activities.

Parents and guardians can also use the digital platform to book vaccination slots and access digital certificates. The system is intended to improve transparency, simplify beneficiary tracking and ensure that vaccination records remain available for future reference.

The digital monitoring mechanism is particularly relevant in a country as large and diverse as India, where healthcare access varies considerably between urban centres, rural communities and geographically difficult areas.

By combining digital records with field-level healthcare activities, authorities aim to ensure that eligible girls are not missed during the implementation of the programme.

Role of Healthcare Workers and Community Awareness

The Health Ministry has highlighted the contribution of medical professionals, including paediatricians, gynaecologists and specialists from leading medical institutions, in building public confidence in HPV vaccination.

Frontline workers such as Accredited Social Health Activists (ASHAs) and Auxiliary Nurse Midwives (ANMs) have also been involved in communicating with families and encouraging participation.

School teachers and community representatives are supporting awareness activities by helping parents understand the purpose of vaccination and the importance of protecting adolescent girls against HPV-related diseases.

Addressing concerns about vaccine safety and effectiveness has remained an important part of the programme. Authorities have stressed the need to provide credible, science-based information and counter misinformation that could discourage families from accessing preventive healthcare.

The campaign has also incorporated state-specific approaches to reach communities with different social, cultural and geographical circumstances. Initiatives undertaken by states such as Bihar, Tamil Nadu and Sikkim have been integrated with the national programme to strengthen implementation.

Safety Measures and Medical Supervision

The government has placed particular emphasis on ensuring the safety of beneficiaries during vaccination sessions.

According to the ministry, all HPV vaccination sessions are conducted at designated government health facilities under the supervision of trained medical officers. Vaccination sites are linked to healthcare centres operating round the clock to facilitate the assessment and management of any rare adverse events following immunisation.

Medical personnel are expected to follow established vaccination safety procedures, including appropriate observation and arrangements for responding to potential complications.

The programme is voluntary and requires parental consent, ensuring that families receive information before deciding whether their daughters should participate.

The ministry has maintained that transparent communication about the benefits and safety arrangements is essential to sustaining public confidence.

Focus Shifts Towards Wider Coverage

With the one-crore-dose milestone achieved, the next challenge for the government is to reach the remaining eligible girls and improve coverage in states and regions where the programme has yet to achieve its full potential.

Although six states have reported complete coverage of their identified target populations, differences in vaccination rates across the country indicate that further efforts will be required to ensure equitable access.

Health authorities are expected to continue working with state governments, district administrations, educational institutions and healthcare professionals to identify gaps and strengthen community outreach.

Parents and guardians of eligible 14-year-old girls have been encouraged to approach their nearest designated government health facility or use the U-WIN platform for information and vaccination appointments.

The achievement of administering more than one crore doses in less than nine months marks an important step in India’s efforts to strengthen preventive healthcare. However, the long-term success of the initiative will depend on maintaining public awareness, ensuring continued access and sustaining high vaccination coverage.

The campaign also highlights a broader shift towards preventing diseases before they become serious health conditions. By combining immunisation, digital monitoring and community participation, India is seeking to reduce the future burden of cervical cancer and improve health outcomes for generations of women.

HPV Vaccine Doses